Dr. Mark Webber’s research group studies how bacteria survive in different conditions. He is particularly interested in bacterial biofilms, mechanisms of antibiotic resistance and understanding bacterial behaviour in communities (including the gut microbiome). His group uses a variety of state-of-the-art molecular microbiology and functional genomics approaches to study bacterial survival and has developed new genome wide functional genomics tools. These are currently being employed to develop improved probiotics and microbiome therapies. Before joining the Quadram Institute Mark led a research group at the University of Birmingham, which he established during a BBSRC David Phillips fellowship studying the evolution of biocide-antibiotic cross resistance. He has published over 85 articles relating to antimicrobials and has acted as an editor for the Journals of Antimicrobial Chemotherapy, Global Antibiotic Resistance and Medical Microbiology as well as PLOS ONE. He acts as an expert adviser to the WHO and FAO in regard to antimicrobial resistance.

The Microbiome Special Interest Group (SIG) aims to accelerate the commercialisation of microbiome-based products and services through community building and knowledge exchange. SIGN UP here for the mailing list for the Microbiomes Special Interest Group to stay up to date with news and upcoming events.